DCC
OXFD

Dow Chemical Company’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Dow Chemical Company’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-275,755
Closed -$4.64M – 107
2014
Q2 		$4.64M Buy
+275,755
New +$4.96M 0.39% 34
2014
Q1 		– Sell
-370,148
Closed -$7.17M – 98
2013
Q4 		$7.17M Buy
+370,148
New +$6.55M 0.59% 15

Other funds holding OXFD

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dow Chemical Company's OXFD Position: Q3 2014 in Review

Dow Chemical Company sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2014, closing a stake of 275,755 shares — an estimated $4.64M sold.

Dow Chemical Company first reported a position in OXFD in Q4 2013 and held it in 2 quarters. The position peaked at $7.17M in Q4 2013. 49 funds tracked by Wall St. Rank hold OXFD as of Q3 2014.

  • Dow Chemical Company reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2014 after selling out during the quarter.
  • Dow Chemical Company sold 275,755 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2014, an estimated $4.64M.
  • Dow Chemical Company first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 2 quarters.
  • Dow Chemical Company's Oxford Immunotec Global PLC Ordinary Shares position peaked at $7.17M in Q4 2013.
  • 49 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2014.

Based on Dow Chemical Company's 13F filing for Q3 2014, filed 13 Nov 2014.